Dr. Ventrapati Pradeep is a highly skilled Medical Oncologist based in Visakhapatnam, Andhra Pradesh. With an impressive experience of 3 years in the field, he is dedicated to providing comprehensive care for patients battling cancer. Dr. Pradeep holds an MBBS degree from the prestigious Andhra Medical College, and he further specialized by obtaining an MD in Radiotherapy from AIIMS, New Delhi, followed by a DM in Medical Oncology from Tata Memorial Hospital in Mumbai. His extensive education equips him with the latest knowledge and techniques in oncological treatment, allowing him to deliver personalized care tailored to each patient's needs.
Fluent in English, Hindi, and Telugu, Dr. Pradeep ensures effective communication with his diverse patient base, fostering an environment of trust and understanding. He has been recognized for his excellence in the field, earning notable awards including Fellow status from MCCR and MSMO, which highlight his commitment to advancing his expertise and contributing positively to the field of oncology.
As part of the Apollo healthcare network, Dr. Ventrapati Pradeep is well-versed in the latest advancements in cancer treatment and is passionate about helping patients achieve their health goals. Whether through innovative therapies, clinical trials, or supportive care, he remains dedicated to improving the lives of his patients and their families during challenging times. With a deep-seated compassion for his patients and a robust academic background, Dr. Pradeep continues to make significant strides in the fight against cancer.
ASSISTANT PROFESSOR, MEDICAL ONCOLOGY FROM 01.08.2022 TO 17.04.2023.
Special interest
Breast & Thoracic Oncology
Neuro-Oncology
Hemato-Oncology
Memberships
Certificates
Fellow – MCCR, MSMO
Memberships
2014 – Present: Life Member, Association of Radiation Oncologists of India (AROI), ID: LM 2244.
Research & Publications
- Anaplastic hemangiopericytoma of eyelid: An unusual location , J Cancer Res Ther. 2017 Jan-Mar;13(1):145-147
- Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience. Journal of Clinical Oncology 2018 36:4_suppl, 857-857
- Pattern of microbial organisms in radiation induced mucositis and dermatitis in head and neck squamous cell carcinoma (HNSCC) treated with radiation (RT)/chemo radiation (CTRT). Journal of Clinical Oncology 2014 32:31_suppl, 210-210
- Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, Janu A, Jain S, Talreja VT, Kapoor A, Kumar Singh G, Khaddar S, Gupta K, Rathinasamy N, Srinivas S, Agrawal A, Ventrapati P, Prabhash K. A real-world data of Immune checkpoint inhibitors in solid tumors from India.
- Cancer Med. 2021 Feb 16. doi: 10.1002/cam4.3617. Epub ahead of print. PMID: 33591635
- Bondili SK, Bagal B, Zawar A, Ventrapati P, Thorat J, Gokarn A, et al. Real-World Outcomes With Generic Pomalidomide in Relapsed Refractory Multiple Myeloma—Experience From a Tertiary Care Cancer Center. JCO Glob Oncol. 2021 Dec;(7):361–7.
- Ramaswamy A, Kothari R, Desouza A, Gupta T, Bairwa S, Kapoor A, et al. Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX. South Asian J Cancer. 2019 Jul;08(03):160–5.
- Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, et al. A real-world data of Immune checkpoint inhibitors in solid tumors from India. Cancer Med. 2021;10(5):1525–34.
- Pradeep V. Time for cancer to be designated a notifiable disease in India. Cancer Res Stat Treat. 2021 Jan 1;4(1):153.
- Bajpai J, Ventrapati P, Joshi S, Wadasadawala T, Rath S, Pathak R, et al. Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India. The Breast. 2021 Dec 1;60:177–84.
- Ventrapati P. Old targets, new bullets, nursing fresh hope. Cancer Res Stat Treat. 2021 Oct 1;4(4):788.
FAQs
Ask your query
Have a question? Ask your query below.
Best Hospital Near me Chennai